Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

1.

[Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].

Shang BY, Shang Y, Zhen YS, Chen SZ.

Yao Xue Xue Bao. 2011 Nov;46(11):1321-5. Chinese.

PMID:
22260022
[PubMed - indexed for MEDLINE]
2.

[Erythromycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].

Chen SZ, Zhang SH, Gong JH, Zhen YS.

Zhonghua Yi Xue Za Zhi. 2006 Dec 19;86(47):3353-7. Chinese.

PMID:
17313833
[PubMed - indexed for MEDLINE]
3.

[Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin].

Chen SZ, Jiang M, Zhen YS.

Ai Zheng. 2005 Aug;24(8):924-9. Chinese.

PMID:
16086867
[PubMed - indexed for MEDLINE]
4.

HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.

Chen SZ, Jiang M, Zhen YS.

Cancer Chemother Pharmacol. 2005 Aug;56(2):212-20. Epub 2005 Apr 6.

PMID:
15812674
[PubMed - indexed for MEDLINE]
5.

Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.

Zhang SH, Zhang H, He HW, Li L, Li XQ, Zhang YP, Shao RG.

Cancer Chemother Pharmacol. 2013 Oct;72(4):777-88. doi: 10.1007/s00280-013-2253-3. Epub 2013 Aug 23.

PMID:
23975242
[PubMed - indexed for MEDLINE]
6.

[Bioluminescence imaging evaluation of the inhibitory effect of lidamycin on lung metastasis of human fibrosarcoma in athymic mice].

Zhang SH, Zhong GS, He HW, Cheng X, Zhen YS.

Yao Xue Xue Bao. 2011 Jan;46(1):45-9. Chinese.

PMID:
21465808
[PubMed - indexed for MEDLINE]
7.
8.

Lidamycin inhibits the cancer cell PKC activity induced by basic fibroblast growth factor.

Zhen HY, Huang YH, Zhen YS.

Yao Xue Xue Bao. 2005 Dec;40(12):1110-5.

PMID:
16496675
[PubMed - indexed for MEDLINE]
9.

[Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].

Yang J, Chen SZ.

Yao Xue Xue Bao. 2010 Oct;45(10):1247-53. Chinese.

PMID:
21348302
[PubMed - indexed for MEDLINE]
10.

HERG K+ channel related chemosensitivity to sparfloxacin in colon cancer cells.

Gong JH, Liu XJ, Shang BY, Chen SZ, Zhen YS.

Oncol Rep. 2010 Jun;23(6):1747-56.

PMID:
20428834
[PubMed - indexed for MEDLINE]
11.

[Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].

Zhang SH, Chen J, Jiang M, Zhen YS.

Yao Xue Xue Bao. 2008 Jun;43(6):601-4. Chinese.

PMID:
18822962
[PubMed - indexed for MEDLINE]
12.

Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.

Zhen HY, He QH, Zhen YZ, Wang SL, Liu YN, Wu WH, Zhang XY, Lu AL, Shen L.

Invest New Drugs. 2011 Dec;29(6):1188-97. doi: 10.1007/s10637-010-9463-x. Epub 2010 Jul 2.

PMID:
20596749
[PubMed - indexed for MEDLINE]
13.

[Comparison of the antitumor activities of immunoconjugates composed of lidamycin and monoclonal antibody fab' fragment with different linkers].

Feng Y, Shao RG, Dai Y, Li BW, He HW, Ren KH.

Yao Xue Xue Bao. 2010 May;45(5):571-5. Chinese.

PMID:
20931757
[PubMed - indexed for MEDLINE]
14.

Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.

Liu H, Li L, Li XQ, Liu XJ, Zhen YS.

Anticancer Drugs. 2009 Jan;20(1):41-9. doi: 10.1097/CAD.0b013e328318292c.

PMID:
19342999
[PubMed - indexed for MEDLINE]
15.

Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.

Li L, Huang YH, Li Y, Wang FQ, Shang BY, Zhen YS.

World J Gastroenterol. 2005 Aug 7;11(29):4478-83.

PMID:
16052675
[PubMed - indexed for MEDLINE]
Free Article
16.

[Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody].

Feng Y, Zhen YS, Dai Y, Shang BY, Zhang M, He HW, Li BW, Shao RG.

Yao Xue Xue Bao. 2007 Jul;42(7):704-9. Chinese.

PMID:
17882952
[PubMed - indexed for MEDLINE]
17.

Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice.

Zhen YZ, Lin YJ, Li Y, Zhen YS.

Acta Pharmacol Sin. 2009 Jul;30(7):1025-32. doi: 10.1038/aps.2009.75.

PMID:
19575006
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy.

Zhang Q, Liu XJ, Hu L, Liao DS, Zheng YB, Zhen YS, Song X.

Int J Mol Med. 2012 Mar;29(3):409-15. doi: 10.3892/ijmm.2011.848. Epub 2011 Nov 22.

PMID:
22108624
[PubMed - indexed for MEDLINE]
19.

Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin.

Fang H, Miao Q, Zhang S, Cheng X, Xiong D, Zhen Y.

Sci China Life Sci. 2011 Mar;54(3):255-62. doi: 10.1007/s11427-011-4143-4. Epub 2011 Mar 16.

PMID:
21416325
[PubMed - indexed for MEDLINE]
20.

Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.

Tang XY, Zhu YQ, Tao WH, Wei B, Lin XL.

Postgrad Med J. 2007 May;83(979):338-43.

PMID:
17488865
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk